EUVIMEDEUVIMED entdecken
Open Access

End-to-end Anastomosis With ECHELON ENDOPATH™ Staple Line Reinforcement for Right-sided Colon Cancer: Safety and Feasibility

Yasuhiro Ishiyama, Yasumitsu Hirano, Megumi Sasaki, Sohei Akuta, Masatoshi Yoshizawa, Misuzu Yamato, Akihito Nakanishi, Yume Minagawa, Hisashi Hayashi, Takatsugu Fujii, Naoto Okazaki, Toshimasa Ishii und 1 weitere

In Vivo · 2025

DOI: 10.21873/invivo.13957 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, 2025. Verfasst von Yasuhiro Ishiyama und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Saitama Medical University International Medical Center, Hidaka, Japan; yishiyama1215@saitama-med.ac.jp. Hauptthemen laut MEDLINE: Anastomosis, Surgical, Colonic Neoplasms, Surgical Stapling. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Functional end-to-end anastomosis (FEEA) is widely utilized in right-sided colorectal cancer surgery for joining the colon and ileum using mechanical staplers. ECHELON ENDOPATH™ Staple Line Reinforcement (SLR), a synthetic absorbable material introduced in 2020, represents a novel approach to reinforcing the anastomosis. However, surgical outcomes of FEEA utilizing SLR remain unreported in the literature. This retrospective study aimed to evaluate the efficacy and safety of FEEA with SLR compared to conventional FEEA in elective right-sided colon cancer surgery. PATIENTS AND METHODS: We conducted a retrospective analysis of 159 consecutive patients who underwent elective surgery for right-sided colon cancer at our institution between February 2019 and December 2022. Short-term surgical outcomes were compared between cohorts receiving FEEA with and without SLR. RESULTS: Analysis revealed no significant differences between groups in operative time, blood loss, postoperative hospital stay duration, or overall complication rates. The SLR group demonstrated a significantly higher proportion of robotic surgical procedures (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anastomosis, SurgicalColonic NeoplasmsSurgical StaplingHumansMaleFemaleAgedMiddle AgedRetrospective StudiesTreatment OutcomeAnastomotic LeakFeasibility StudiesAged, 80 and overOperative TimePostoperative ComplicationsRobotic Surgical Procedures

Stichwörter der Autor:innen

ECHELON ENDOPATH™ SLRFunctional end-to-end anastomosis (FEEA)right-sided colon cancer surgeryrobotic colorectal surgerystaple line reinforcement (SLR)

Autor:innen und Institutionen

  • Department of Gastroenterological Surgery, Saitama Medical University International Medical Center, Hidaka, Japan; yishiyama1215@saitama-med.ac.jp.
  • Department of Gastroenterological Surgery, Saitama Medical University International Medical Center, Hidaka, Japan.
  • Department of Gastrointestinal Surgery, Tokyo Medical and Dental University, Tokyo, Japan.

Zitieren

APA

Ishiyama, Y., Hirano, Y., Sasaki, M., Akuta, S., Yoshizawa, M., Yamato, M., Nakanishi, A., Minagawa, Y., Hayashi, H., Fujii, T., Okazaki, N., Ishii, T., & Hiranuma, C. (2025). End-to-end Anastomosis With ECHELON ENDOPATH™ Staple Line Reinforcement for Right-sided Colon Cancer: Safety and Feasibility. In Vivo. https://doi.org/10.21873/invivo.13957

Vancouver

Ishiyama Y, Hirano Y, Sasaki M, Akuta S, Yoshizawa M, Yamato M, et al. End-to-end Anastomosis With ECHELON ENDOPATH™ Staple Line Reinforcement for Right-sided Colon Cancer: Safety and Feasibility. In Vivo. 2025. doi:10.21873/invivo.13957

BibTeX
@article{Ishiyama2025,
  author = {Ishiyama, Yasuhiro and Hirano, Yasumitsu and Sasaki, Megumi and Akuta, Sohei and Yoshizawa, Masatoshi and Yamato, Misuzu and Nakanishi, Akihito and Minagawa, Yume and Hayashi, Hisashi and Fujii, Takatsugu and Okazaki, Naoto and Ishii, Toshimasa and Hiranuma, Chikashi},
  title = {End-to-end Anastomosis With ECHELON ENDOPATH™ Staple Line Reinforcement for Right-sided Colon Cancer: Safety and Feasibility},
  journal = {In Vivo},
  year = {2025},
  doi = {10.21873/invivo.13957}
}
Kostenlos starten →